Nippon India Pharma Fund - IDCW - Regular Plan

Other Plans and Options
  • 0.47 %Nav, as on 12-05-2025

  • Previous Nav

  • Net Change on 12-05-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIPPON INDIA PHARMA FUND - IDCW Option 4.83 -2.61 15.32 21.14 21.80 20.22
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
BSE SENSEX - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
NIPPON INDIA PHARMA FUND - IDCW Option Jun 05, 2004 15.32 21.14 21.80 1.80 8,259.60
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - IDCW Option Jul 13, 2018 22.53 25.20 24.72 1.91 5,295.32
SBI Healthcare Opportunities Fund - Regular Plan - Income Distribution cum Capital Withdrawal Option (IDCW) Jul 03, 1999 21.51 25.89 24.34 1.94 3,670.62
Mirae Asset Healthcare Fund Regular IDCW Jul 02, 2018 17.53 19.66 21.71 1.94 2,682.70
TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option Dec 28, 2015 15.92 21.38 21.42 2.15 1,222.72
TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum capital withdrawal option Dec 28, 2015 15.92 21.38 21.42 2.15 1,222.72

Fund Holdings as on 30-April-2025

  • Sun Pharmaceutical Industries Limited

  • Divi's Laboratories Limited

  • Lupin Limited

  • Cipla Limited

  • Apollo Hospitals Enterprise Limited

  • Dr. Reddy's Laboratories Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • MedPlus Health Services Limited

  • Vijaya Diagnostic Centre Limited

  • Abbott India Limited

  • Ajanta Pharma Limited

  • Narayana Hrudayalaya Limited

  • Gland Pharma Limited

  • Aurobindo Pharma Limited

  • Dr. Lal Path Labs Limited

  • Zydus Lifesciences Limited

  • Torrent Pharmaceuticals Limited

  • Alkem Laboratories Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Mankind Pharma Limited

  • Thyrocare Technologies Limited

  • Sanofi India Limited

  • Pfizer Limited

  • IPCA Laboratories Limited

  • Sanofi Consumer Healthcare India Limited

  • Sai Life Sciences Limited

  • Suraksha Diagnostic Limited

  • Fortis Healthcare Limited

  • Biocon Limited

  • Syngene International Limited

  • AstraZeneca Pharma India Limited

  • Indoco Remedies Limited

  • Orchid Pharma Limited

  • Emcure Pharmaceuticals Limited

  • Krishna Institute Of Medical Sciences Limited

  • Triparty Repo

  • Concord Biotech Limited

  • Akums Drugs and Pharmaceuticals Limited

  • Cash Margin - CCIL

  • Net Current Assets

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Business Support

  • Miscellaneous

View More

Fund Manager

Most Recent Dividend

  • 21/02/2025

  • 26/02/2024

  • 28/02/2022

  • 01/03/2021

  • 02/03/2020

  • 05/03/2019

  • 05/03/2018

  • 06/03/2017

  • 08/03/2016

  • 02/02/2015

  • 17/02/2014

  • 14/01/2013

  • 16/03/2012

  • 28/02/2011

  • 31/08/2009

  • 24/03/2008

  • 22/02/2007

  • 19/12/2005

  • Cash

  • Equity

View More

About Nippon India Pharma Fund

Scheme Analysis

Nippon India Pharma Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Nippon India Mutual Fund. It was launched on 05-Jun-2004 and currently has an AUM of ₹8,259.60 crore. Nippon India Pharma Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.

The NAV of Nippon India Pharma Fund ended up ₹0.53(0.47%)yesterday to ₹113.3473.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Nippon India Pharma Fund is managed by Sailesh Raj Bhan .

Fund House Contact

4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W) Mumbai - 400 013

022-68087000
022-68087097